UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.08B |
| 2 |
UBS Group
UBS
|
+$643M |
| 3 |
Southwest Airlines
LUV
|
+$588M |
| 4 |
Medtronic
MDT
|
+$505M |
| 5 |
Workday
WDAY
|
+$497M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.51B |
| 2 |
Tesla
TSLA
|
+$1.13B |
| 3 |
Apple
AAPL
|
+$976M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$803M |
| 5 |
Chevron
CVX
|
+$688M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.35% |
| 2 | Technology | 17.79% |
| 3 | Financials | 9.18% |
| 4 | Industrials | 6.66% |
| 5 | Consumer Discretionary | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BOWNU
7026
DELISTED
Bowen Acquisition Corp Unit
BOWNU
| $111K | ﹤0.01% |
8,802
| – | – |
2025 Q1
2 quarters
|
|
|
BTAI
7027
DELISTED
BioXcel Therapeutics
BTAI
| $111K | ﹤0.01% |
43,542
+3,660
| +9% | +$11.5K |
2018 Q1
30 quarters
|
|
|
MFI
7028
mF International
MFI
$478M
| $111K | ﹤0.01% |
3,008
-1,345
| -31% | -$46.5K |
2025 Q2
1 quarter
|
|
|
PCAPU
7029
ProCap Acquisition Corp Unit
PCAPU
$214M
| $111K | ﹤0.01% |
10,609
-1,701
| -14% | -$17.9K |
2025 Q2
1 quarter
|
|
|
ARAI
7030
Arrive AI Inc
ARAI
$11.2M
| $111K | ﹤0.01% |
30,485
-8,211
| -21% | -$54.5K |
2025 Q2
1 quarter
|
|
7031
Stabilis Solutions
SLNG
$89.8M
| $111K | ﹤0.01% |
25,361
-6,143
| -19% | -$27K |
2025 Q1
2 quarters
|
|
|
RANGU
7032
Range Capital Acquisition Corp Units
RANGU
| $110K | ﹤0.01% |
10,611
| – | – |
2024 Q4
3 quarters
|
|
7033
BayFirst Financial Corp
BAFN
$198M
| $110K | ﹤0.01% |
10,542
-6,420
| -38% | -$71.7K |
2024 Q4
3 quarters
|
|
|
SENEB
7034
Seneca Foods Class B
SENEB
$1.18B
| $110K | ﹤0.01% |
+1,033
| New | +$109K |
2025 Q3
0 quarters
|
|
7035
NetSol Technologies
NTWK
$68.7M
| $110K | ﹤0.01% |
23,122
-101,153
| -81% | -$422K |
2023 Q3
8 quarters
|
|
|
NREF
7036
NexPoint Real Estate Finance
NREF
$297M
| $110K | ﹤0.01% |
7,737
+4,545
| +142% | +$65.5K |
2022 Q2
13 quarters
|
|
7037
Entrada Therapeutics
TRDA
$221M
| $110K | ﹤0.01% |
18,910
-5,849
| -24% | -$34.2K |
2022 Q4
11 quarters
|
|
7038
FT Vest US Equity Enhance & Moderate Buffer ETF January
XJAN
$43.2M
| $110K | ﹤0.01% |
3,042
-6,284
| -67% | -$223K |
2024 Q2
5 quarters
|
|
7039
inTEST
INTT
$154M
| $109K | ﹤0.01% |
14,017
-9,532
| -40% | -$70K |
2021 Q4
15 quarters
|
|
7040
Bionano Genomics
BNGO
$18.5M
| $109K | ﹤0.01% |
63,876
+61,206
| +2,292% | +$195K |
2019 Q2
25 quarters
|
|
7041
Concrete Pumping Holdings
BBCP
$498M
| $109K | ﹤0.01% |
15,470
-1,661
| -10% | -$11.6K |
2019 Q1
26 quarters
|
|
|
TAOX
7042
Tao Synergies Inc
TAOX
$32.9M
| $109K | ﹤0.01% |
+16,609
| New | +$120K |
2025 Q3
0 quarters
|
|
7043
Virginia National Bankshares
VABK
$260M
| $109K | ﹤0.01% |
2,802
+989
| +55% | +$38.4K |
2021 Q2
17 quarters
|
|
|
OMSE
7044
OMS Energy Technologies
OMSE
$188M
| $108K | ﹤0.01% |
25,526
+22,797
| +835% | +$144K |
2025 Q2
1 quarter
|
|
|
STRZ
7045
Starz Entertainment Corp
STRZ
$391M
| $108K | ﹤0.01% |
7,364
-10,052
| -58% | -$146K |
2025 Q2
1 quarter
|
|
7046
Fidelity Fundamental Large Cap Growth ETF
FFLG
$638M
| $108K | ﹤0.01% |
+3,676
| New | +$103K |
2025 Q3
0 quarters
|
|
7047
CALL
Diageo
DEO
$46.9B
| $108K | ﹤0.01% |
1,134
| – | – |
2025 Q1
2 quarters
|
|
7048
MarketWise
MKTW
$55.5M
| $108K | ﹤0.01% |
6,516
+2,108
| +48% | +$38.6K |
2022 Q3
12 quarters
|
|
|
RECT
7049
Rectitude Holdings
RECT
$19.5M
| $108K | ﹤0.01% |
29,012
-7,885
| -21% | -$34.8K |
2025 Q1
2 quarters
|
|
7050
Cytosorbents Corp
CTSO
$13.2M
| $108K | ﹤0.01% |
5,760
-357
| -6% | -$7.03K |
2017 Q4
31 quarters
|
|
Similar funds
UBS Group's Q3 2025 Portfolio in Review
As of Q3 2025, UBS Group held 11,340 positions worth $638B, up 11% from $578B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group's Q3 2025 filing shows 1,171 new, 4,183 increased, 4,475 reduced and 1,086 closed positions. Its largest new stake was Paramount Skydance Corp: 13,287,677 shares worth $251M. The largest sale was NVIDIA, an estimated $1.51B.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 36% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q3 2025 buy was Paramount Skydance Corp: 13,287,677 shares worth $251M.
- UBS Group added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $1.08B increase.
- UBS Group's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $1.51B.
- UBS Group fully exited Hess in Q3 2025, selling an estimated $442M.
- UBS Group's ten largest holdings make up 16% of its $638B portfolio in Q3 2025.
- UBS Group opened 1,171 new positions and closed 1,086 in Q3 2025.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $638B.
Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.